Panos Gkoutzios

Panos Gkoutzios

Auto-generated profile, based on publicly available information

Panos Gkoutzios

Academic Department of Vascular Surgery, St Thomas' Hospital, South Bank Section, School of Cardiovascular and Metabolic Medicine & Sciences, King's British Heart Foundation Centre of Research Excellence, King's College London, Westminster Bridge Road, London, SE1 7EH, United Kingdom

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Clinical Imaging
Verified
Journal Article
Closed access
APArman Parsai
Arman Parsai
IZImene Zerizer
Imene Zerizer
OROran Roche
Oran Roche
PGPanos Gkoutzios
Panos Gkoutzios
MMMarc Miquel
Marc Miquel

1 August 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
VZVassilios Zymvragoudakis
Vassilios Zymvragoudakis
TDTommaso Donati
Tommaso Donati
PGPanos Gkoutzios
Panos Gkoutzios
SASaid Abisi
Said Abisi

27 December 2021 in Vascular
Verified
Journal Article
Closed access
PDF file
ADAthanasios Diamantopoulos
Athanasios Diamantopoulos
RNRomman Nourzaie
Romman Nourzaie
DMDoug Mulholland
Doug Mulholland
SDSteven G Dolan
Steven G Dolan
IAIrfan Ahmed
Irfan Ahmed
TSTarun Sabharwal
Tarun Sabharwal
Objectives: This article aims to present a prospective study investigating the safety and efficacy of the Mynx Control extravascular closure device (Cordis Corporation, FL, USA), for femoral arterial closure in patients undergoing peripheral arterial procedures. Methods: Between January 2020 and February 2021, 100 Mynx Control devices were deployed in 91 consecutive patients (mean age: 67.5 ± 16.9 years) who underwent peripheral arterial procedures. We used ultrasound and/or fluoroscopy during Mynx Control deployment and ultrasound post-procedure to detect complications. Femoral artery punctures included 62 (62%) antegrade and 38 (38%) retrograde punctures. The mean activated clotting time at time of device deployment was 221s. The primary endpoints were technical success, device failure, and complication rates up to 30 days. Results: A 5F vascular sheath was used in 43 cases (43%) (36 (36%) 6F and 21 (21%) 7F). The majority of our cases had antegrade access (62%). Overall technical success rate was 97% in both antegrade and retrograde cases. In total, there were 4 minor complications: 3 (3%) cases of pseudoaneurysm and 1 (1%) case of haematoma. No major complications were recorded post-procedure or 30 days post index procedure. Conclusion: The Mynx Control vascular closure device is safe and effective in achieving haemostasis in patients undergoing antegrade and retrograde peripheral angioplasty procedures.

23 March 2026 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Open access
MRMichael Greshan Rasiah
Michael Greshan Rasiah
TKTom J.A.J. Konings
Tom J.A.J. Konings
ANAmanda Nio
Amanda Nio
SMStefano Moriconi
Stefano Moriconi
APAshish S. Patel
Ashish S. Patel
BMBijan Modarai
Bijan Modarai
To develop an in-silico model of the aorta and its spinal cord-supplying branches, using it to characterise haemodynamic changes following aortic aneurysm (AA) repair. The work is motivated by the risk of spinal cord ischaemia (SCI) and paraplegia, serious complications that can arise from disruption of spinal cord perfusion during AA surgery. An objective, patient-specific tool capable of predicting changes in spinal cord blood flow pre-intervention would address a critical unmet clinical need. SimVascular was used to retrospectively model a 76-year-old female patient's aorta pre- and post-uncomplicated endovascular thoraco-abdominal AA repair. The full extent of the aorta and its branches, including spinal cord-supplying vessels, was segmented. Pulsatile flow simulations were conducted under the assumption of rigid walls, with patient-specific inlet and three-element Windkessel models for the outlet boundary conditions on the SimVascular Gateway Cluster. Haemodynamic changes following (staged) stent graft implantation were evaluated, alongside key surface-based metrics: time-averaged wall shear stress (TAWSS), oscillatory shear index (OSI), relative residence time (RRT) and endothelial cell activation potential (ECAP) were assessed primarily focussing on spinal cord-supplying vessels. Postoperatively, segmental artery flow to the spinal cord decreased by 51.86% following exclusion of lumbar and posterior intercostal arteries by the stent. Spinal cord-supplying arteries showed increased TAWSS (+5.2%) and reduced RRT and ECAP, with minimal change in OSI. Modest flow increases were observed in non-spinal vascular beds, including the legs (+6.09%), reno-visceral vessels (+5.89%), and supra-aortic branches (+5.97%). Across vascular territories, visceral arteries had the highest TAWSS and lowest RRT/ECAP, while leg arteries had the lowest TAWSS and highest RRT/ECAP; supra-aortic vessels exhibited the highest OSI. Simulating a hypothetical first-stage thoracic stent deployment demonstrated an 18.2% reduction in spinal cord-directed flow, compared with the 51.9% reduction after complete repair, illustrating the pipeline's capacity to compare surgical strategies. This study lays a foundation for computational prediction of SCI risk. It leverages in-silico modelling, using open-source software and routine medical imaging, to assess spinal cord blood flow alterations after aortic surgery. Scaling to more patients and enriching physiological detail of models may forge a path towards a clinical decision-making tool.